A summary of an ICER cost-effectiveness analysis published in JMCP found that despite incremental clinical benefits, biologics used to treat asthma have low long-term value for money.
A systematic review published in JMCP demonstrates that while life expectancy in HIV patients has increased, there is an increased incidence of age- and ART-associated comorbidities. This has important implications for future cost effectiveness analysis.
A systematic review published in JMCP demonstrates that while life expectancy in HIV patients has increased, there is an increased incidence of age- and ART-associated comorbidities. This has important implications for future cost effectiveness analysis.
Genomic testing technology is rapidly evolving, but these test are costly and analytically complex. This article, published in JMCP, suggests a standardized method for the development and application of clinically relevant genomic testing.
Genomic testing technology is rapidly evolving, but these test are costly and analytically complex. This article, published in the JMCP, suggests a standardized method for the development and application of clinically relevant genomic testing.
